Larvol Delta - BiomarkerGuided-Ruxolitinib-for-the-Prevention-of-Chronic-Graft-Versus-Host-Disease-After-Allogeneic-Hematopoietic-Cell-Transplantation

Jakafi (ruxolitinib) - Incyte

http://clinicaltrials.gov/ct2/show/NCT07025538

Sep 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next